OUTCOME AND PROGNOSTIC FACTORS IN PATIENTS WITH HODGKIN LYMPHOMA (HL) WHO REMAIN PET/CT-POSITIVE AFTER ABVD COMBINATION CHEMOTHERAPY: POTENTIAL APPLICATIONS FOR THE DESIGN OF SUBSEQUENT TREATMENTT. Vassilakopoulos,P. Rontogianni,G. Pangalis,G. Boutsikas,V. Prassopoulos,S. Masouridis,S. Kokoris,M. Dimou,Z. Galani,S. Chatziioannou,M. Moschogiannis,S. Sachanas,X. Yiakoumis,V. Pappi,E. Sinni,T. Tzenou,K. Petevi,A. Kanellopoulos, T. Ntalagiorgos,I. Vardounioti,K. Koutsi,L. Papageorgiou,E. Pessach,V. Telonis,E. Variamis,M. C. Kyrtsonis,M. Dimopoulou,M. Siakantaris,P. Beris,I. Datseris,P. Panayiotidis, I. Meletis,M. AngelopoulouHAEMATOLOGICA(2012)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要